PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32733956-9 2020 Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 via inhibiting p38MAPK phosphorylation. coomassie Brilliant Blue 25-41 interleukin 1 beta Rattus norvegicus 156-173 32733956-9 2020 Inhibition of P2X7R with Brilliant Blue G (BBG) reversed neuropathic pain might decrease through the expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6 via inhibiting p38MAPK phosphorylation. coomassie Brilliant Blue 43-46 interleukin 1 beta Rattus norvegicus 156-173 30570747-8 2019 The microinjection of the P2X7R antagonist brilliant blue G (BBG, a non-competitive P2X7R antagonist) into the RVM prevented the development of mechanical allodynia, inhibited the activation of microglia, and decreased the expression of IL-1beta and 8-hydroxyguanine in the RVM following SMIR. coomassie Brilliant Blue 43-59 interleukin 1 beta Rattus norvegicus 237-245 30570747-8 2019 The microinjection of the P2X7R antagonist brilliant blue G (BBG, a non-competitive P2X7R antagonist) into the RVM prevented the development of mechanical allodynia, inhibited the activation of microglia, and decreased the expression of IL-1beta and 8-hydroxyguanine in the RVM following SMIR. coomassie Brilliant Blue 61-64 interleukin 1 beta Rattus norvegicus 237-245 25873133-10 2015 Following trauma, BBG treatment significantly reduced the levels of PKCgamma and interleukin-1beta in the cortex. coomassie Brilliant Blue 18-21 interleukin 1 beta Rattus norvegicus 81-98 25873133-11 2015 The results provide in vivo evidence that BBG exerted neuroprotective effects by attenuating brain edema and improving neurological functions via reducing PKCgamma and interleukin-1beta levels following TBI. coomassie Brilliant Blue 42-45 interleukin 1 beta Rattus norvegicus 168-185 25933224-6 2015 BBG also ameliorated liver fibrosis and down-regulated hepatic interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), PDGF, IL-1beta, transforming growth factor-beta (TGF-beta), p-extracellular-signal-regulated kinases (ERK), and alpha-smooth muscle actin (alpha-SMA) expressions in CBDL rats. coomassie Brilliant Blue 0-3 interleukin 1 beta Rattus norvegicus 132-140 15965498-4 2005 The increase in plasma concentrations of IL-1beta and IL-6, measured 1 h after LPS treatment, was reduced by PPADS (25 mg kg(-1)) and BBG (100 mg kg(-1)). coomassie Brilliant Blue 134-137 interleukin 1 beta Rattus norvegicus 41-49